Skip to content
10-Q

Quarterly Report

Indaptus Therapeutics, Inc. INDP

0001493152-25-021759

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 1.75M sh
Shares Diluted Q3 2025 · Sep 30, 2025 997.04K sh
Shares Diluted Q3 2025 · Sep 30, 2025 689.17K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 339.66K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 315.45K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$11.63M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$8.93M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $5.83M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $5.79M
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.61M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1.67M
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.8M
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.94M
Stockholders Equity Q3 2025 · Sep 30, 2024 $6M
Stockholders Equity Q3 2025 · Jun 30, 2024 $6.17M
Stockholders Equity Q3 2025 · Mar 31, 2024 $9.36M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.23M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.39M
Current Assets Q3 2025 · Sep 30, 2025 $6.44M
Current Assets Q3 2025 · Dec 31, 2024 $6.62M
Total Assets Q3 2025 · Sep 30, 2025 $6.84M
Total Assets Q3 2025 · Dec 31, 2024 $7.34M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.98
Eps Diluted Q3 2025 · Sep 30, 2025 −$18.48
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$9.04
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$34.53
Eps Basic Q3 2025 · Sep 30, 2025 −$2.98
Eps Basic Q3 2025 · Sep 30, 2025 −$18.48
Eps Basic restated Q3 2025 · Sep 30, 2024 −$9.04
Eps Basic restated Q3 2025 · Sep 30, 2024 −$34.53
Sga Expense Q3 2025 · Sep 30, 2025 $1.13M
Sga Expense Q3 2025 · Sep 30, 2025 $5.18M
Sga Expense Q3 2025 · Sep 30, 2024 $1.68M
Sga Expense Q3 2025 · Sep 30, 2024 $6.42M
Rd Expense Q3 2025 · Sep 30, 2025 $1.52M
Rd Expense Q3 2025 · Sep 30, 2025 $6.5M
Rd Expense Q3 2025 · Sep 30, 2024 $1.47M
Rd Expense Q3 2025 · Sep 30, 2024 $4.77M
Net Income Q3 2025 · Sep 30, 2025 −$2.98M
Net Income Q3 2025 · Sep 30, 2025 −$12.74M
Net Income Q3 2025 · Jun 30, 2025 −$5.23M
Net Income Q3 2025 · Mar 31, 2025 −$4.53M
Net Income Q3 2025 · Sep 30, 2024 −$3.07M
Net Income Q3 2025 · Sep 30, 2024 −$10.89M
Net Income Q3 2025 · Jun 30, 2024 −$4.02M
Net Income Q3 2025 · Mar 31, 2024 −$3.81M
Operating Income Q3 2025 · Sep 30, 2025 −$2.65M
Operating Income Q3 2025 · Sep 30, 2025 −$11.68M
Operating Income Q3 2025 · Sep 30, 2024 −$3.14M
Operating Income Q3 2025 · Sep 30, 2024 −$11.19M